KRN7000 applied to lymphoma research

NKT Cell Responses to B Cell Lymphoma

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B cell lymphoma
















New 7DW8-5 glycolipid


Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch


Meet Funakoshi Company
at the following meetings:

Philadelphia, PA
December 2-6, 2017